Cutaneous Toxicities of Molecular Targeted Therapies

Antineoplastic targeted therapies, such as EGFR inhibitors, tyrosine kinase inhibitors and BRAF inhibitors, frequently lead to systemic and cutaneous side effects, significantly affecting patient’s quality of life. Patients with new targeted therapies have an increased risk of developing skin reacti...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Maedica (Bucur)
Главные авторы: STANCULEANU, Dana Lucia, ZOB, Daniela, TOMA, Oana Catalina, GEORGESCU, Bogdan, PAPAGHEORGHE, Laura, MIHAILA, Raluca Ioana
Формат: Artigo
Язык:Inglês
Опубликовано: EDITORIAL POINT OF VIEW 2017
Предметы:
State of the Art
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574072/
https://ncbi.nlm.nih.gov/pubmed/28878837
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы